Brookline Capital analyst Kumaraguru Raja initiates coverage on SAB Biotherapeutics (NASDAQ:SABS) with a Buy rating and announces Price Target of $8. SAB Biotherapeutics Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Company Profile. SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of. The current price of SABS is USD — it has decreased by −% in the past 24 hours. Watch SAB Biotherapeutics, Inc. stock price performance more closely. View a financial market summary for SABS including stock price quote, trading volume, volatility, options volume, statistics, and other important company.
SAB Biotherapeutics (SABS) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. View the latest SAB Biotherapeutics Inc. (SABS) stock price, news, historical charts, analyst ratings and financial information from WSJ. SAB Biotherapeutics Inc SABS:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date10/30/23 · 52 Week Low Get the latest SAB Biotherapeutics Inc. (SABS) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. About SAB Biotherapeutics (SABS) ; 52 week range. $ - $ ; 5 year debt / equity. x ; Beta (LTM). x ; Interest coverage. x ; Dividend & yield. Stock Price Forecast. The 3 analysts with month price forecasts for SAB Biotherapeutics stock have an average target of 13, with a low estimate of and a. In the current month, SABS has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SABS average Analyst price target in the past 3 months is $ Key stats ; Shares outstanding. M · Market cap. $M ; Price to earnings (P/E). N/A. Price to book (P/B). Price to sales (P/S). EV/EBIT. N/A. EV. Price Performance ; 1-Month. unch. on 08/02/ %. on 07/11/ (%). since 07/02/24 ; 3-Month. +%. on 05/23/ %. During the last trading day the stock fluctuated % from a day low at $ to a day high of $ The price has fallen in 6 of the last 10 days and is down. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. SABS will report earnings.
SABS Stock Performance ; Previous close, ; Day range, - ; Year range, 2 - 10 ; Market cap, 24,, ; Primary exchange, NASDAQ. SAB Biotherapeutics Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · SABS Overview · Key Data · Performance · Analyst Ratings. Sell. Discover historical prices for SABS stock on Yahoo Finance. View daily, weekly or monthly format back to when SAB Biotherapeutics, Inc. stock was issued. SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies. Discover real-time SAB Biotherapeutics, Inc. Common Stock (SABS) stock prices, quotes, historical data, news, and Insights for informed trading and. Price Performance ; 1-Month. unch. on 08/02/ %. on 07/11/ (%). since 07/02/24 ; 3-Month. +%. on 05/23/ %. SABS SAB Biotherapeutics Inc. 1, $ $ (%). Today. Watchers, 1, Wk Low, $ Wk High, $ Market Cap, $M. The stock price for SAB Biotherapeutics (NASDAQ: SABS) is $ last updated August 29, at AM EDT. Q. Does SAB Biotherapeutics (SABS) pay a dividend? Get the latest SAB Biotherapeutics Inc (SABS) real-time quote, historical performance, charts, and other financial information to help you make more.
(NASDAQ: SABS) Sab Biotherapeutics stock price per share is $ today (as of Jun 21, ). What is Sab Biotherapeutics's Market Cap. Stock Quote & Chart. Breadcrumb. Home · Investors; Stock Quote & Chart. Stock Quote. NASDAQ: SABS. $ Aug 27, PM EDT. Change. View today's SAB Biotherapeutics Inc stock price and latest SABS news and analysis. Create real-time notifications to follow any changes in the live stock. View the real-time SABS price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Get SAB Biotherapeutics Inc (birskdd.ru) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
SAB Biotherapeutics Inc Registered ShsStock, SABS ; Income Statements in Mio. USD · Sales, ; Balance Sheet in Mio. USD · Total liabilities, ; Key Data in. View SAB Biotherapeutics (SABS) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. SAB Biotherapeutics,. is a Biotechnology company with market cap of $ Million. Today, SABS stock price is , PS ratio is , Revenue is $ M. SAB Biotherapeutics, Inc. (birskdd.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock SAB Biotherapeutics. SABS - SAB Biotherapeutics Inc - Stock screener for investors and traders, financial visualizations.
American Funds Best Performing Funds | Courses To Learn About Stock Market